Haig Goenjian, MD
Psychiatry · Long Beach, CANPI 1831487438
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Johnson & Johnson at 49.8% of the total. Reporting peaked in 2019 at $13,837 and has fallen 75.8% since, to $3,352 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $315.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$11K
- Alkermes, Inc.$6K
- AbbVie$3K
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$161
- Axsome Therapeutics, Inc.$123
- plus $302 from 5 others
Across 291 payments — averaging $21,574 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.5M
- Sumitomo Pharma America, Inc.$1.4M
- Sanofi Pasteur Inc.$721K
- Bioxcel Therapeutics, Inc.$685K
- E.r. Squibb & Sons, L.L.C.$634K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$550K
- plus $761K from 9 others
What the payments were for
- Consulting fees$7,75034%
- Speaking & faculty fees$10,25044%
- Travel & lodging$2,64311%
- Food & beverage$2,34810%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 33 | $11,479 |
| Alkermes, Inc. | 9 | $5,557 |
| AbbVie | 1 | $3,250 |
| Neurocrine Biosciences, Inc. | 15 | $2,167 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $161 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $102 |
| Boehringer Ingelheim | 1 | $83 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $68 |
| Indivior Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$20,942
- SPRAVATO$11,033
- ARISTADA INITIO$5,235
- Auvelity$123
- COBENFY$102
How this compares
$23,038 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone OdtRisperidone | 44 | $12,516 |
| Olanzapine OdtOlanzapine | 92 | $7,167 |
| Aripiprazole | 74 | $4,033 |
| Fluphenazine Hcl | 17 | $3,768 |
| Clozapine | 40 | $3,765 |
| Divalproex Sodium | 95 | $2,456 |
| Risperidone | 156 | $2,199 |
| Olanzapine | 97 | $1,994 |
| Quetiapine Fumarate | 95 | $1,556 |
| AmantadineAmantadine Hcl | 13 | $1,088 |
| Trazodone Hcl | 67 | $759 |
| Ziprasidone Hcl | 19 | $643 |
| Sertraline Hcl | 113 | $576 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $557 |
| Benztropine Mesylate | 39 | $547 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Long Beach
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.